Tags

Type your tag names separated by a space and hit enter

Folic acid supplementation and neural tube defect recurrence prevention.
Birth Defects Res A Clin Mol Teratol 2007; 79(11):737-42BD

Abstract

BACKGROUND

It is well established that women who have had a pregnancy affected by a neural tube defect (NTD) have an elevated risk of a subsequent NTD-affected pregnancy and that a high dose (4 mg/day) of folic acid taken around the time of conception prevents most recurrences of NTDs.

METHODS

We reviewed the literature to identify studies that quantify the reduction in risk if women with a prior-NTD affected pregnancy consistently take folic acid before and during a subsequent pregnancy and the effectiveness of NTD recurrence prevention programs in increasing the percentage of women who consistently consume folic acid supplements.

RESULTS

A meta-analysis of randomized trials of folic acid for the prevention of recurrent NTDs indicates a 69% reduction in recurrence risk if analyzed on an intention-to-treat basis and an 87% reduction among those women who took supplements prior to the beginning of pregnancy. Observational studies report reductions in recurrence risk of 85% to 100% among women taking folic acid prior to subsequent pregnancies. The percentage of women who take folic acid prior to a subsequent pregnancy has been reported to vary from 33% to 85%, varying with the demographic background and the intensity of folic acid counseling efforts.

CONCLUSIONS

Targeted folic acid information and counseling provided to women with an NTD-affected pregnancy has been demonstrated to substantially reduce the risk of recurrent NTDs and is feasible to implement on a public health basis.

Links

  • Publisher Full Text

    • Authors+Show Affiliations

    Grosse SD
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
    Collins JS
    No affiliation info available

    MeSH

    Dietary SupplementsFemaleFolic AcidHealth Knowledge, Attitudes, PracticeHumansNeural Tube DefectsPregnancyPrenatal CareRandomized Controlled Trials as TopicRecurrence

    Pub Type(s)

    Journal Article
    Meta-Analysis

    Language

    eng

    PubMed ID

    17990333

    Citation

    Grosse, Scott D., and Julianne S. Collins. "Folic Acid Supplementation and Neural Tube Defect Recurrence Prevention." Birth Defects Research. Part A, Clinical and Molecular Teratology, vol. 79, no. 11, 2007, pp. 737-42.
    Grosse SD, Collins JS. Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Res Part A Clin Mol Teratol. 2007;79(11):737-42.
    Grosse, S. D., & Collins, J. S. (2007). Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Research. Part A, Clinical and Molecular Teratology, 79(11), pp. 737-42.
    Grosse SD, Collins JS. Folic Acid Supplementation and Neural Tube Defect Recurrence Prevention. Birth Defects Res Part A Clin Mol Teratol. 2007;79(11):737-42. PubMed PMID: 17990333.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Folic acid supplementation and neural tube defect recurrence prevention. AU - Grosse,Scott D, AU - Collins,Julianne S, PY - 2007/11/9/pubmed PY - 2008/1/30/medline PY - 2007/11/9/entrez SP - 737 EP - 42 JF - Birth defects research. Part A, Clinical and molecular teratology JO - Birth Defects Res. Part A Clin. Mol. Teratol. VL - 79 IS - 11 N2 - BACKGROUND: It is well established that women who have had a pregnancy affected by a neural tube defect (NTD) have an elevated risk of a subsequent NTD-affected pregnancy and that a high dose (4 mg/day) of folic acid taken around the time of conception prevents most recurrences of NTDs. METHODS: We reviewed the literature to identify studies that quantify the reduction in risk if women with a prior-NTD affected pregnancy consistently take folic acid before and during a subsequent pregnancy and the effectiveness of NTD recurrence prevention programs in increasing the percentage of women who consistently consume folic acid supplements. RESULTS: A meta-analysis of randomized trials of folic acid for the prevention of recurrent NTDs indicates a 69% reduction in recurrence risk if analyzed on an intention-to-treat basis and an 87% reduction among those women who took supplements prior to the beginning of pregnancy. Observational studies report reductions in recurrence risk of 85% to 100% among women taking folic acid prior to subsequent pregnancies. The percentage of women who take folic acid prior to a subsequent pregnancy has been reported to vary from 33% to 85%, varying with the demographic background and the intensity of folic acid counseling efforts. CONCLUSIONS: Targeted folic acid information and counseling provided to women with an NTD-affected pregnancy has been demonstrated to substantially reduce the risk of recurrent NTDs and is feasible to implement on a public health basis. SN - 1542-0752 UR - https://www.unboundmedicine.com/medline/citation/17990333/Folic_acid_supplementation_and_neural_tube_defect_recurrence_prevention_ L2 - https://doi.org/10.1002/bdra.20394 DB - PRIME DP - Unbound Medicine ER -